Association of ACE, FABP2 and GST genes polymorphism with essential hypertension risk among a North Indian population

References

• Aguilar-Salinas CA, Olaiz G, Valles V, Franco A, Olaiz G, Sepúlveda J. 2001. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 42:1298–1307
   PubMed Web of Science ®Google Scholar
• Angelats EG, Sierra A, Enjuto M, Pare JC, Rivera F, de La Sierra A. 2000. Lack of association between ACE gene polymorphism and left ventricular hypertrophy in essential hypertension. J Hum Hypertens 14:47–49
   PubMed Web of Science ®Google Scholar
• Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, Oesch F. 1996. Multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 236:184–186
   PubMed Web of Science ®Google Scholar
• Badaruddoza, Bhanwer AJS, Sawhney R, Randhawa NK, Matharoo K, Barna B. 2002. A study of Angiotensin Converting Enzyme (ACE) gene polymorphism in essential hypertension among a business community in Punjab. Int J Hum Genet 9:231–234
   Google Scholar
• Bae Y, Park C, Han J, Kajino M, Engardt M, Bennet C. 2007. Interaction between GNB3 C825T and ACE I/D polymorphisms in essential hypertension in Koreans. J Hum Hypertens 21:159–166
   PubMed Web of Science ®Google Scholar
• Baier LJ, Bogardus C, Sacchettini J. 1996. A polymorphism in the human intestinal fatty-acid-binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 271:10892–10896
   PubMed Web of Science ®Google Scholar
• Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA. 1995. An amino acid substitution in the human fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation and insulin resistance. J Clin Invest 34:249–266
   Google Scholar
• Bessa SS, Ali EM, Hamdy SM. 2009. The role of glutathione S- transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension. Eur J Intern Med 20:625–630
   PubMed Web of Science ®Google Scholar
• Capoluongo E, Onder G, Concolino P, Russo A, Santonocitoa C, Bernabei R, Zuppi C, et al. 2009. GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente Geographic Area (ilSIRENTE study). Clin Chim Acta 399:92–96
   PubMed Web of Science ®Google Scholar
• Chen X, Touyz RM, Park JB, Schiffrin EL. 2001. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38:606–611
   PubMed Web of Science ®Google Scholar
• Cracowski JL, Durand T, Bessard G. 2002. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci 23:360–366
   PubMed Web of Science ®Google Scholar
• Dalal AB, Tewari D, Tewari S, Pradhan M, Gupta UR, Sinha N. 2006. Association of coronary artery disease with polymorphisms of Angiotensin converting enzyme and Methylenetetrahydrofolate reductase gene. Indian Heart J 58:330–335
   PubMedGoogle Scholar
• de Luis DA, Sagrado MG, Aller R, Izaola O, Conde R, Romero E. 2009. Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients. Obes Surg 19:1691–1696
   PubMed Web of Science ®Google Scholar
• Doney AS, Lee S, Leese GP, Morris AD, Palmer CN. 2005. Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation 111:2927–2934
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
   PubMed Web of Science ®Google Scholar
• Frova C. 2006. Glutathione transferases in the genomics era: new insights and perspectives. Biomol Eng 23:149–169
   PubMedGoogle Scholar
• Georgopoulos A, Aras O, Tsai MY. 2000. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 85:3155–3160
   PubMed Web of Science ®Google Scholar
• Gesang L, Liu G, Cen W, Qiu C, Zhuoma C, Zhuang L. 2002. Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibetan population. Hypertens Res 25:481–485
   PubMed Web of Science ®Google Scholar
• Gomez LC, Real SM, Ojeda MS, Gimenez S, Mayorga LS, Roqué M. 2007. Polymorphism of the FABP2 gene: a population frequency analysis and an association study with cardiovascular risk markers in Argentina. BMC Med Genet 8:39
   PubMed Web of Science ®Google Scholar
• González R, Blanca E, Karla E, Aguilar-Salinas CA, Canizales-Quinteros S, Rojas-Martínez R. 2011. Polymorphisms of seven genes involved in lipid metabolism in an unselected Mexican population. J Genet 90:e114–e119
   PubMed Web of Science ®Google Scholar
• Guettier JM Georgopoulos A, Tsai MY, Radha V, Shanthirani S, Deepa R, Gross M, et al. 2005. Polymorphisms in the Fatty Acid-Binding Protein 2 and Apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab 90:1705–1711
   PubMed Web of Science ®Google Scholar
• Gupta R. 2006. Rethinking diseases of affluence; coronory heart disease in developing countries. S Asian J Prevent Cardiol 10:65–78
   Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. 2005. Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88
   Google Scholar
• Hori M, Oniki K, Ueda K, Goto S, Mihara S, Marubayashi T, Nakagawa K. 2007. Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against type 2 diabetes in Japanese. Pharmacogenomics 8:1307–1314
   PubMed Web of Science ®Google Scholar
• Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, Tsai JH. 2000. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 15:1008–1013
   PubMed Web of Science ®Google Scholar
• Hsu KT, Storch J. 1996. Fatty acid transfer from liver and intestinal fatty-bindig proteins to membranes occurs by differents mechanisms. J Biol Chem 271:13317–13323
   PubMed Web of Science ®Google Scholar
• Hubert C, Houot AM, Corvol P, Soubrier F. 1991. Structure of the angiotensin I-converting enzyme gene: Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 266:15377–15383
   PubMed Web of Science ®Google Scholar
• Hussain K, Salah N, Hussain S, Hussain S. 2012. Investigate the role of Glutathione S Transferase (GST) Polymorphism in development of hypertension in UAE population. Iran Red Crescent Med J 14:479–482
   PubMed Web of Science ®Google Scholar
• Hwa Han J, Lee HJ, Cho MR, Yun KE, Jeong H, Choi HJ, Kang MH. 2011. Association between glutathione S-transferase (GST) M1 and T1 Polymorphisms and subclinical hypertension in Korean population. FASEB J 25:782.8
   Google Scholar
• Ismail M, Akhtar N, Nasir M, Firasat S, Ayub Q, Khaliq S. 2004. Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and essential hypertension in young Pakistani patients. J Biochem Mol Biol 37:552–555
   PubMedGoogle Scholar
• Kearney PM, Whelton M, He J. 2005. Global Burden of HTN: analysis of worldwide data. Lancet 365:217–223
   PubMed Web of Science ®Google Scholar
• Kennon B, Petrie JR, Small M, Connell JM. 1999. Angiotensin- converting enzyme gene and diabetes mellitus. Diabet Med 16:448–458
   PubMed Web of Science ®Google Scholar
• Ketterer B. 1998. Glutathione S-transferases and prevention of cellular free radical damage. Free Radic Res 28:647–658
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim MG, Kim KS, Song JS, Yim SV, Chung JH. 2008. Impact of Glutathione S-Transferase M1 and T1 Gene Polymorphisms on the smoking-related coronary artery disease. J Korean Med Sci 23:365–372
   PubMed Web of Science ®Google Scholar
• Kohta N, Yoshiji Y, Hitoshi M, Watanabe S, Kato K. 2007. Association of gene polymorphisms with myocardial infarction in individuals with or without conventional coronary risk factors. Int J Mol Med 19:129–141
   PubMed Web of Science ®Google Scholar
• Lee BK, Lee SJ, Joo JS, Cho KS, Kim NS, Kim HJ. 2012. Association of Glutathione S-transferase genes (GSTM1 and GSTT1) polymorphisms with hypertension in lead-exposed workers. Mol Cell Toxicol 8:203–208
   Web of Science ®Google Scholar
• Lopez ER, Madrigal BR, Canaveral IH, Panduro A. 2007. Association of the T54 allele of the FABP2 gene with cardiovascular risk factors in obese Mexican subjects. Diabetes Vasc Dis Res 4:235–236
   PubMedGoogle Scholar
• Mahboob M, Khan H, Sharif A. 2002. Association between Angiotensin I – Converting enzyme gene polymorphism and hypertension in selected individuals of the Bangladeshi population. J Biochem Mol Biol 35:251–254
   PubMedGoogle Scholar
• Marinho C, Alho I, Arduıno D, Falcaob LM, Nogueira JB, Bicho M. 2007. GST M1/T1 and MTHFR polymorphisms as risk factors for hypertension. Biochem Biophys Res Commun 353:344–350
   PubMed Web of Science ®Google Scholar
• Martin C, Marju OM, Jan H. 2000. The T 54 Allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke. J Clin Endocrinol Metabol 85:2801–2804
   PubMed Web of Science ®Google Scholar
• Mattei MG, Hubert C, Alhenc-Gelas F. 1989. Angiotensin converting enzyme is on chromosome 17. Cytogenet Cell Genet 51:1041–1045
   Google Scholar
• McIlwain CC, Townsend DM, Tew KD. 2006. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25:1639–1648
   PubMed Web of Science ®Google Scholar
• Miranda-Vilela AL, Akimoto1 AK, Alves PCZ, Ferreira LB, Lordelo GS, Melo JGM, Grisolia CK, et al. 2010. Evidence for an association between haptoglobin and MnSOD (Val9Ala) gene polymorphisms in essential hypertension based on a Brazilian case-control study. Genet Mol Res 9:2166–2175
   PubMed Web of Science ®Google Scholar
• Moleda P, Majkowska L, Safranow K, Celewicz Z, Fronczyk A, Majkowska L. 2007. Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients. Przegl Lek 64:134–139
   PubMedGoogle Scholar
• Mondry A, Loh M, Liu P, Zhu AL, Nagel M. 2005. Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrol 6:1
   PubMedGoogle Scholar
• Obineche EN, Frossard PM, Bokhari AM. 2001. An association study of five genetic loci and left ventricular hypertrophy amongst Gulf Arabs. Hypertens Res 24:635–639
   PubMed Web of Science ®Google Scholar
• Park K. 2005. Park’s textbook of preventive and social medicine. 18th ed. Jabalpur: M/s Banarasidas Bhanot Publishers
   Google Scholar
• Pedrinelli R, Giulia D, Giuseppe P, Bandinelli S, Bertini A. 2006. ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension. Clin Sci 111:357–364
   PubMed Web of Science ®Google Scholar
• Petrovic D, Peterlin B. 2014. GSTM1-null and GSTT1-null genotypes are associated with essential arterial hypertension in patients with type 2 diabetes. Clin Biochem 47:574–577
   PubMed Web of Science ®Google Scholar
• Pradeepa R, Mohan V. 2008. HTN and pre HTN in developing countries. Indian J Med Res 128:688–690
   PubMed Web of Science ®Google Scholar
• Pratley RE, Baier L, Pan DA, Salbe AD, Storlien L, Ravussin E, Bogardus C. 2000. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 41:2002–2008
   PubMed Web of Science ®Google Scholar
• Qu H, Lu Y, Lin S. 2001. Meta-analysis on the association of ACE/ID polymorphism and essential HTN in Chinese population. Zhonghua Yu Fang Yi Xue Za Zhi 35:408–411
   PubMedGoogle Scholar
• Ramachandran V, Patimah I, Johnson S. 2008. Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjects. J Renin Angiotensin Aldosterone Syst 9:208–214
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346
   PubMed Web of Science ®Google Scholar
• Salem AH. 2008. Distribution of angiotensin converting enzyme insertion/deletion gene polymorphism among two Arab populations. Suez Canal Univ Med J Vol. II, Mo. 1:125–130
   Google Scholar
• Sambrook J, Frisch EF, Maniatis T, editors. 1989. Molecular cloning; a labortory manual. 2nd ed. New York: Cold Sping Harbor Labortory Press. p 9.14–9.19
   Google Scholar
• Schiffrin EL. 2002. Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens 15:115S–122S
   PubMed Web of Science ®Google Scholar
• Sipahi T, Budak M, Sen S, Ay A, Sener S. 2006. Association between ACE gene insertion I/deletion D polymorphism and primary hypertension in Turkish patients of Trakya region. Biotechnol Biotechnol 20:104–108
   Google Scholar
• Taal MW. 2000. Angiotensin-converting enzyme gene polymorphisms in renal disease: clinically relevant? Curr Opin Nephrol Hypertens 9:651–657
   PubMed Web of Science ®Google Scholar
• Vimaleswaran KS, Radha V, Mohan V. 2006. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Metabolism 55:1222–1226
   PubMed Web of Science ®Google Scholar
• Wang R, Wang Y, Wang J, Yang K. 2012. Association of glutathione S-transferase T1 and M1 gene polymorphisms with ischemic stroke risk in the Chinese Han population. Neural Regen Res 7:1420–1427
   PubMed Web of Science ®Google Scholar
• Wang X, Wang S, Lin R. 2004. GNB3 gene C825T and ACE gene I/D polymorphisms in essential hypertension in a Kazakh genetic isolate. J Hum Hypertens 18:663–668
   PubMed Web of Science ®Google Scholar
• Weiss EP, Brown MD, Shuldiner AR, Hagberg JM. 2002. Fatty Acid binding protein-2 gene variants an insulin resistance: gene and gene-environment interaction effects. Physiol Genomics 10:145–157
   PubMed Web of Science ®Google Scholar
• Yamada K, Yuan X, Ishiyama S, Shoji S, Kohno S, Koyama K. 1997. Association between Ala54Thr substitution of the Fatty acid binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40:706–710
   PubMed Web of Science ®Google Scholar
• Zee RY, Ridker PM, Stampfer MJ, Hennekens CH, Lindpaintner K. 1999. Prospective evaluation of the angiotensin- converting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation 99:340–343
   PubMed Web of Science ®Google Scholar